Vymbixis Trademark Details

Vymbixis was registered on Tuesday, June 25, 2013 and is currently owned by Sanofi under the registration number 4356721 . This mark is alive with a status of Registered. The last case file activity for this mark occured 10 years ago on Tuesday, June 25, 2013, according to the United State Patent & Trademark Office
Word Mark Vymbixis
Status Alive Registered 700 — Registered

Current Owner

Sanofi of Paris, TX

View all trademarks for Sanofi
Other Trademarks for Sanofi
Serial Number 85646315
Registration Number 4356721
Status Date Tuesday, June 25, 2013
Filing Date Tuesday, June 25, 2013
Registration Date Tuesday, June 25, 2013
Attorney Susan Upton Douglass
Domestic Representative Susan Upton Douglass

Correspondent

SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK, NY 10017-1822

Case File Statements

Goods & Services Pharmaceutical Preparations for the Prevention and Treatment of Cardiovascular Diseases, Cancer, Thrombosis, Viral Infections, Diseases of the Central Nervous System, and Respiratory Diseases

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, June 18, 2012
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.